Investigating the Influence of Covariates on Axicabtagene Ciloleucel (axi-cel) Kinetics in Patients with Non-Hodgkin’s LymphomaMagali Chartier, Rhine R. Shen, Simone Filosto et al.|Clinical Pharmacokinetics|2024Cited by 5
First-in-human study of ABBV-621 in patients (pts) with previously treated sold tumours: Dose-optimization cohortsEmiliano Calvo, Patricia LoRusso, Yu‐Wei Chang et al.|Annals of Oncology|2019Cited by 1